Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 57 for:    redhill

Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04723537
Recruitment Status : Recruiting
First Posted : January 25, 2021
Last Update Posted : April 15, 2021
Sponsor:
Information provided by (Responsible Party):
RedHill Biopharma Limited

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : September 2021